Evanson Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Evanson Financial’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$217K	Buy	+4,000	New	+$180K	0.01%	301

Other funds holding ARKG

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return

Gimbal Financial Carmel, Indiana $172M AUM

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Evanson Financial's ARKG Position: Q3 2026 in Review

Evanson Financial opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 4,000 shares worth $217K. The stake represents 0.01% of the portfolio and ranks #301 among its holdings.

179 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

Evanson Financial held 4,000 shares of ARK Genomic Revolution ETF worth $217K as of Q3 2026.
ARK Genomic Revolution ETF was a new Evanson Financial position in Q3 2026.
ARK Genomic Revolution ETF made up 0.01% of Evanson Financial's portfolio in Q3 2026, its #301 holding.
179 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Evanson Financial's 13F filing for Q3 2026, filed 23 Oct 2026.